Genetics of hypertension: Lessons learnt from Mendelian and polygenic syndromes

Clinical and Experimental Hypertension

Volumn 26, Issue 7-8, 2004, Pages 611-620

  Dominiczak, Anna F ^a   Brain, Nick ^a   Charchar, Fadi ^a   McBride, Martin ^a   Hanlon, Neil ^a   Lee, Wai Kwong ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Genomics; Hypertension; Pharmacogenetics; Single nucleotide polymorphisms

Indexed keywords

APPARENT MINERALOCORTICOID EXCESS SYNDROME; BRACHYDACTYLY; COMPARATIVE GENE MAPPING; CONFERENCE PAPER; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC PROCEDURES; GENETICS; GENOMICS; GLUCOCORTICOID REMEDIABLE ALDOSTERONISM; GORDON SYNDROME; HUMAN; HYPERTENSION; LIDDLE SYNDROME; MATERNAL HYPERTENSION; MENDELIAN HYPERTENSION; MULTIFACTORIAL INHERITANCE; PHARMACOGENETICS; PSEUDOHYPOALDOSTERONISM; SINGLE NUCLEOTIDE POLYMORPHISM;

GENOMICS; HUMANS; HYPERTENSION; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 12344264734     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200031939     Document Type: Conference Paper

References (27)

1. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33(suppl):228-237.
2. Alberts MJ. Genetic aspects of cerebrovascular disease. Stroke 1991; 22:276-280.
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
4. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355:262-265.
5. Shimkets RA, Lifton RP, Canessa CM. The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem 1997; 272:25537-25541.
6. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112.
7. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 1988; 82:340-349.
8. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289:119-123.
9. Schuster H, Wienker TE, Bahring S, Bilginturan N, Toka HR, Neitzel H, Jeschke E, Toka O, Gilbert D, Lowe A, Ott J, Haller H, Luft FC. Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet 1996; 13:98-100.
10. Baker EH, Dong YB, Sagnella GA, Rothwell M, Onipinla AK, Markandu ND, Cappuccio FP, Cook DG, Persu A, Corvol P, Jeunemaitre X, Carter ND, MacGregor GA. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet 1998; 351:1388-1392.
11. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000; 36:477-483.
12. Erlich PM, Cui J, Chazaro I, Farrer LA, Baldwin CT, Gavras H, DeStefano AL. Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension 2003; 41:1191-1195.
13. Anderson NH, Dominiczak AF. Genetic analysis of complex traits. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Emery and Rimoin's: Principles and Practice of Medical Genetics. Vol. 1. Churchhill Livingstone, 2002:410-424, Chapter 12.
14. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
15. Wang JG, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000; 410:289-302.
16. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592.
17. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
18. Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, Ogata J, Ogihara T. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation 2000; 101:2060-2065.
19. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19:1349-1358.
20. Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003; 361:1734-1738.
21. Samani NJ. Genome scans for hypertension and blood pressure regulation. Am J Hypertens 2003; 16:167-171.
22. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop M, Farrall M, Connell J. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361:2123.
23. Jacob HJ, Kwitek AE. Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet 2002; 3:33-42.
24. Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY. Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35:164-172.
25. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension 2003; 41:847-853.
26. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31:273-300.
27. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000; 405:857-865.